This site uses cookies to collect activity data and personalize content. By continuing to navigate this site, you agree to allow us to collect information using cookies. Learn more about how we care for your data in our privacy notice.

Accept

Self-injection of DMPA-SC in Ghana, Malawi, DRC, Senegal, and Uganda

Thousands of women are now taking charge of their reproductive health through self-injection of the contraceptive subcutaneous DMPA (DMPA-SC, brand name Sayana® Press). In this February 13, 2019 webinar, speakers presented evidence from five countries at different stages of DMPA-SC introduction and scale-up, from earliest (Ghana) to more advanced (Uganda). Speakers also shared insights on applying research findings to program design and delivery. This webinar was hosted by the DMPA-SC Access Collaborative Learning and Action Network.

For more information, visit www.path.org/dmpa-sc, sign up for our newsletter, or email FPoptions@path.org.

Publication date: February 2019

Available materials

    1. Self-injection of DMPA-SC in Ghana, Malawi, DRC, Senegal, and Uganda: increasing access, improving continuation, and empowering women

      Webinar recording

    2. Self-injection of DMPA-SC in Ghana, Malawi, DRC, Senegal, and Uganda: increasing access, improving continuation, and empowering women 5.4 MB PDF

      Webinar presentation slides